Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Prednisolone Conjugated Polypropylene Imine Dendritic Architecture Confers Reducing Hemolytic Toxicity- A Comparative Study

Ramadoss Karthikeyan and Palanirajan Vijayaraj Kumar

The present study was aimed to design Prednisolone conjugated-5.0G PPI dendrimer and evaluate comparative preliminary hemolytic toxicity . The hemolytic toxicity study was conducted among free 5.0G PPI dendrimer, designed Prednisolone conjugated-5.0G PPI dendrimer and PEGylated- PPI dendrimer. The degree of hemolysis was compared with the amount of released hemoglobin from RBC was estimated by UV-spectrophotometric determination at 540nm (n=3). PEGylation has been found to be suitable for modification of ethylene diamine initiator core EDA-PPI dendrimers in various research outcomes. The results of comparative hemolytic toxicity studies observed that the toxicity viz Prednisolone conjugated-5.0G PPI dendrimer is 1.42 ± 0.52, PEGylated dendrimer 2.72 ± 1.10 and free dendrimer found to be 20.39±0.82 respectively. In this study hemolytic toxicity of synthesized systems are also relatively safer and hold potential to deliver some bioactive.